Effect of Core Stability Training on Segmental Trunk Control and Quality of Life in Children with Cerebral Palsy

February 6, 2025 updated by: Tamer Mohamed El-Saeed, Cairo University

Effect of Core Stability Training on Segmental Trunk Control and Quality of Life in Children with Spastic Diplegia: a Randomized Controlled Trial

Spastic diplegia is a common shape of cerebral palsy that significantly affects trunk control and quality of life in children. Core stability training (CST) has been utilized as a potential intervention to improve the trunk function. This study investigated the effects of CST on segmental trunk control and quality of life in children with spastic diplegia.

Forty children with spastic diplegia (age: 3 - 6 years) were randomly assigned to either a control group (n=20) receiving a selected physical therapy program or an experimental group (n=20) receiving the same program plus a 30-minute CST program three times weekly for 12 weeks. Segmental trunk control was assessed using the Segmental Assessment of Trunk Control (SATCO) scale, and quality of life was measured using the Pediatric Quality of Life Inventory (PedsQL). Both outcome measures were evaluated pre- and post-intervention.

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cairo
      • Giza, Cairo, Egypt, 12613
        • Faculty of physical therapy, Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 3-6 years
  • 1 to 1+ spasticity according to modified Ashworth scale
  • level II and III according to GMFCs
  • able to follow instructions and understand commands

Exclusion Criteria:

  • significant visual or auditory problems
  • fixed deformities
  • Botox injection
  • orthopedic surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Core Stability Training
receive an experimental intervention in form of functional exercises to improve core
Program of exercises to enhance function
Active Comparator: Traditional physical therapy
Traditional physical therapy used to treat the same condition
Exercises to improve function of children with CP

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Segmental Assessment of Trunk Control scale
Time Frame: Baseline and after 12 weeks of training
Higher scores mean a better outcome. Minimum Score: 0 (No control at any level) Maximum Score: 14 (Full control at all seven levels, each scoring 2)
Baseline and after 12 weeks of training
Quality of Life Inventory Scale
Time Frame: Baseline and after 12 weeks of training
Higher scores mean a better outcome. Minimum Score: 0 (poorest quality of life) Maximum Score: 100 (best quality of life)
Baseline and after 12 weeks of training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

September 30, 2023

Study Registration Dates

First Submitted

December 15, 2024

First Submitted That Met QC Criteria

February 6, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 6, 2025

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on Designed rehabilitation program

Subscribe